Nepi Rockcastle NV
F:0A3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nepi Rockcastle NV
F:0A3
|
NL |
|
W
|
Wheaton Precious Metals Corp
XMUN:SII
|
CA |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
Fairvest Ltd
F:2T20
|
ZA |
|
A
|
Anthem Inc
LSE:0HG8
|
US |
|
C
|
Champion Real Estate Investment Trust
OTC:CMPNF
|
HK |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
W
|
WEX Inc
F:WL9
|
US |
|
C
|
COSCO SHIPPING Development Co Ltd
XMUN:EZ5
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A3's stock price target?
Not Available
0A3 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nepi Rockcastle NV?
Projected CAGR
-3%
Over the last 2 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is -3%.
What is the Operating Income forecast for Nepi Rockcastle NV?
Projected CAGR
7%
Over the last 2 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 2 years is 7%.
What is the Net Income forecast for Nepi Rockcastle NV?
Projected CAGR
1%
Over the last 2 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 3 years is 1%.
